Price T Rowe Associates Inc Evolus, Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$62.9 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$45.3 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$35.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$33.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$31.8 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $613M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...